Results 101 to 110 of about 57,705 (278)

Options for early breast cancer follow-up in primary and secondary care : a systematic review [PDF]

, 2012
Background Both incidence of breast cancer and survival have increased in recent years and there is a need to review follow up strategies. This study aims to assess the evidence for benefits of follow-up in different settings for women who have had ...
A David, AB Moadel, AJ Winzelberg, AK Sandgren, Association_of_Breast_Surgery_at_BASO, B Pestalozzi, BL Andersen, Brown Loise SPGR, C Sheppard, CARS Robertson, Chagari Cea, D Chapman, D Palli, D Vaile, DA Montgomery, DA Montgomery, DA Montgomery, DM Gujral, E Grunfeld, E Grunfeld, E Grunfeld, E Grunfeld, E Kog, Early Breast Cancer Trialists' Collaborative G, Frances Taggart, Ganz, Ganz, GM Chlebowski RT, HM Milne, I Koinberg, I Soerjomataram, IL Koinberg, J Khatcheressian, Janet Dunn, JL Khatcheressian, JM Dixon, JMP Donnelly, K Beaver, KD Meneses, KL Taylor, KM Clough-Gorr, KS Courneya, KS Courneya, L Bertelsen, M Churn, M Grogan, M Jiwa, M Kimman, M Kontos, M Kriege, M Rosselli Del Turco, M Schaapveld, M van Hezewijk, M Vanhuyse, MJC van der Sangen, ML Irwin, ML Kimman, ML Kimman, ML McNeely, MP Coleman, MP Rojas, N Houssami, N Mutrie, National-Institute-for-Health-and-Clinical-Excellence, P Donnelly, P Donnelly, P-H Zahl, PA Ganz, PA Ganz, PA Ganz, Peter Donnelly, PJ Vos, PK Donnelly, R Knols, R Nikander, R Peto, S Lebel, S Lebel, SA Murray, Sheppard, T Gulliford, TF Hack, TK Yau, TL Lash, TL Lash, V Kataja, W Lu, X Gao, Y Chen, Y Chen   +89 more
core   +3 more sources

Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations

Precision Medical Sciences, EarlyView.
Breast cancer subtypes, estrogen receptor‐positive (ER+), HER2‐enriched, and TNBC, are defined by genomic and epigenetic signatures. Multi‐omics profiling, immunotherapy, liquid biopsy, and AI‐driven radiogenomics enable precision medicine. Tools like Oncotype DX and PAM50 support personalized care.
Samina Malik, Arif Malik, Shahzad Ahmad, Hassan Mohsin, Shazia Iqbal   +4 more
wiley   +1 more source

Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors

Cancer Treatment and Research Communications
Breast cancer is a leading cause of death among women globally. Estrogen receptor (ER)-positive breast cancers account for ∼70 % of breast cancer diagnoses worldwide. Endocrine therapy is the primary treatment approach for ER-positive breast cancer.
Nayoung Kim, Kiven Erique Lukong
doaj   +1 more source

Aromatase inhibitors in post-menopausal endometriosis

Reproductive Biology and Endocrinology, 2011
Postmenopausal endometriosis is a rare clinical condition. The diagnosis and treatment of an endometriotic lesion in postmenopausal women is complicated.
Devroey Paul, Velasco Juan-Garcia, Kyrou Dimitra, Grimbizis Grigoris, Zavos Apostolos, Fatemi Human M, Polyzos Nikolaos P, Tarlatzis Basil, Papanikolaou Evangelos G   +8 more
doaj   +1 more source

Sex Hormones and the Risk of Nasal Polyps: A Two‐Sample Mendelian Randomization Study

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective The pathophysiological roles of sex hormones in airway inflammation have drawn much attention recently. We aimed to explore the causal effect of sex hormones on chronic rhinosinusitis (CRS) and nasal polyps (NP) via a Mendelian randomization (MR) study.
Ying Zhu, Jia‐Yao Zhou, Shi‐Yao Zhang, Ru Tang, Chun‐Yu Luo, Yue‐Long Gu, Zhi‐Peng Li, Wei‐Tian Zhang   +7 more
wiley   +1 more source

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer

Case Reports in Hematology, 2015
Aromatase inhibitors (AIs) are most commonly used for breast cancer patients with hormone receptor positive disease. Although the side effect profile of aromatase inhibitors is well known, including common side effects like arthralgia, bone pain ...
Sri Lakshmi Hyndavi Yeruva, Stanley Madu Nwabudike, Onyekachi Henry Ogbonna, Patricia Oneal   +3 more
doaj   +1 more source

Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer

, 2022
Jessica A. Martinez, Betsy C. Wertheim, Denise J. Roe, Pavani Chalasani, Jules Cohen, Lea Baer, H.‐H. Sherry Chow, Alison Stopeck, Patricia A. Thompson   +8 more
openalex   +2 more sources

Targeted therapy for breast cancer prevention. [PDF]

, 2013
With a better understanding of the etiology of breast cancer, molecularly targeted drugs have been developed and are being testing for the treatment and prevention of breast cancer.
Brown, Powel H, den Hollander, Petra, Savage, Michelle I   +2 more
core   +2 more sources

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells

Breast Cancer Research, 2017
Background Approximately 70% of all breast cancers express the estrogen receptor, and are regulated by estrogen. While the ovaries are the primary source of estrogen in premenopausal women, most breast cancer is diagnosed following menopause, when ...
Derek F. Amanatullah, John S. Tamaresis, Pauline Chu, Michael H. Bachmann, Nhat M. Hoang, Deborah Collyar, Aaron T. Mayer, Robert B. West, William J. Maloney, Christopher H. Contag, Bonnie L. King   +10 more
doaj   +1 more source